Requirements for investigational device exemption (IDE) studies approved by the Centers for Medicare & Medicaid Services (CMS)

Thank you for visiting First Coast Service Options' Medicare provider website. This website is intended exclusively for Medicare providers and health care industry professionals to find the latest Medicare news and information affecting the provider community.

To enable us to present you with customized content that focuses on your area of interest, please select your preferences below:

Select which best describes you: Health Care Professional Person(s) with Medicare

This website provides information and news about the Medicare program for health care professionals only. All communication and issues regarding your Medicare benefits are handled directly by Medicare and not through this website. For the most comprehensive experience, we encourage you to visit Medicare.gov or call 1-800-MEDICARE. In the event your provider fails to submit your Medicare claim, please view these resources for claim assistance.

Home ► Clinical trials ► Requirements for investigational device exemption (IDE) studies approved by the Centers for Medicare & Medicaid Services (CMS)

Last Modified: 7/16/2020 Location: FL, PR, USVI Business: Part A, Part B

Requirements for investigational device exemption (IDE) studies approved by the Centers for Medicare & Medicaid Services (CMS)

Effective January 1, 2015, CMS outlined criteria for coverage of IDE studies and changed from local Medicare administrative contractor (MAC) review and approval of IDE studies to a centralized review and approval of IDE studies (with a 2015 Food and Drug Administration (FDA) approval letter). The complete process change is available on the following website: https://www.cms.gov/Medicare/Coverage/IDE external link

Prior to submitting claims for CMS-approved IDEs, sites participating in a CMS-approved IDE are requested to submit the following to First Coast at clinicaltrials@fcso.com:

• A copy of CMS’ letter to the sponsor approving the IDE

• A cover letter or email with the following information:

Name of the principal investigator

Point of contact name and email address

The name of the Part A facility and address where the services will be performed

The Agency for Health Care Administration (AHCA) for that facility. The facility AHCA number may be found at the following website address: http://www.floridahealthfinder.gov/FacilityLocator/facloc.aspx external link

Note: For FDA IDE approvals prior to January 1, 2015, First Coast will continue to require investigational study sites to submit the required documents listed on the checklist available at https://medicare.fcso.com/Clinical_trials/157082.pdf pdf file

for the contractor’s review to clinicaltrials@fcso.com.

First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.